MX2010000856A - Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. - Google Patents

Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.

Info

Publication number
MX2010000856A
MX2010000856A MX2010000856A MX2010000856A MX2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A
Authority
MX
Mexico
Prior art keywords
preparation
calcium channel
channel antagonist
pharmaceutical composition
composition containing
Prior art date
Application number
MX2010000856A
Other languages
English (en)
Spanish (es)
Inventor
Evangelos Karavas
Efthimios Koutris
Ioanna Koutri
Eleni Sthathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000856(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of MX2010000856A publication Critical patent/MX2010000856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
MX2010000856A 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. MX2010000856A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
MX2010000856A true MX2010000856A (es) 2010-04-30

Family

ID=39223083

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010000856A MX2010000856A (es) 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Country Status (20)

Country Link
EP (2) EP2180883B1 (ko)
JP (2) JP5769963B2 (ko)
KR (2) KR101632079B1 (ko)
CN (3) CN101784260A (ko)
AU (2) AU2007356942B2 (ko)
BR (2) BRPI0721883A2 (ko)
CA (2) CA2691752C (ko)
CO (1) CO6290639A2 (ko)
CR (1) CR11285A (ko)
EA (2) EA021645B1 (ko)
EC (1) ECSP109984A (ko)
ES (2) ES2622495T3 (ko)
MA (1) MA31684B1 (ko)
MX (2) MX2010000856A (ko)
MY (1) MY153857A (ko)
NZ (2) NZ582648A (ko)
TN (2) TN2010000011A1 (ko)
UA (2) UA97161C2 (ko)
WO (2) WO2009012791A1 (ko)
ZA (2) ZA201000586B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
AU2007356942B2 (en) * 2007-07-23 2011-12-15 Pharmathen S.A. Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
EP2414356B1 (en) * 2009-04-03 2015-09-02 F.Hoffmann-La Roche Ag Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
CN106220623A (zh) 2009-11-06 2016-12-14 普莱希科公司 用于激酶调节的化合物和方法及其适应症
EA028821B9 (ru) 2011-02-07 2018-10-31 Плексксикон, Инк. Соединения и способы для модуляции киназ, а также показания к их применению
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
ZA200605290B (en) * 2003-12-01 2007-10-31 Lifecycle Pharma As Pharmaceutical compositions comprising lercanidipine
AU2004294674B2 (en) * 2003-12-01 2009-02-26 Recordati Ireland Limited Pharmaceutical compositions comprising lercanidipine
ES2547226T5 (es) * 2006-08-30 2020-06-12 Jagotec Ag Formulaciones de dosificación oral de liberación controlada que comprenden un núcleo y una o más capas de barrera
EP2101771A2 (en) * 2006-12-06 2009-09-23 Torrent Pharmaceuticals Ltd Stable lercanidipine formulation
AU2007356942B2 (en) * 2007-07-23 2011-12-15 Pharmathen S.A. Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Also Published As

Publication number Publication date
KR20100045456A (ko) 2010-05-03
CR11285A (es) 2010-04-27
EP2170295A1 (en) 2010-04-07
EA021645B1 (ru) 2015-08-31
MX2010000801A (es) 2010-07-05
KR101512404B1 (ko) 2015-04-21
JP5769963B2 (ja) 2015-08-26
WO2009012791A1 (en) 2009-01-29
BRPI0814666A2 (pt) 2017-05-09
EP2170295B1 (en) 2015-04-22
TN2010000022A1 (en) 2011-09-26
KR20100047848A (ko) 2010-05-10
NZ582648A (en) 2012-06-29
CO6290639A2 (es) 2011-06-20
ECSP109984A (es) 2010-04-30
JP2010534211A (ja) 2010-11-04
MA31684B1 (fr) 2010-09-01
ES2537063T3 (es) 2015-06-02
EA201000220A1 (ru) 2010-08-30
EP2180883A1 (en) 2010-05-05
EA201070160A1 (ru) 2010-06-30
TN2010000011A1 (en) 2011-09-26
AU2007356942A1 (en) 2009-01-29
KR101632079B1 (ko) 2016-06-20
AU2008280106B9 (en) 2014-08-07
AU2007356942B2 (en) 2011-12-15
JP2010534220A (ja) 2010-11-04
ZA201001176B (en) 2010-11-24
UA97161C2 (ru) 2012-01-10
ZA201000586B (en) 2011-03-30
UA99136C2 (ru) 2012-07-25
MY153857A (en) 2015-03-31
CN101801347A (zh) 2010-08-11
WO2009013306A1 (en) 2009-01-29
EA019614B1 (ru) 2014-05-30
BRPI0721883A2 (pt) 2014-02-18
EP2180883B1 (en) 2017-01-11
CN101784260A (zh) 2010-07-21
AU2008280106B2 (en) 2014-03-20
CA2691752A1 (en) 2009-01-29
NZ582690A (en) 2011-12-22
CA2693233A1 (en) 2009-01-29
AU2008280106A2 (en) 2010-02-25
CN103976968A (zh) 2014-08-13
AU2008280106A1 (en) 2009-01-29
ES2622495T3 (es) 2017-07-06
CA2691752C (en) 2016-01-26

Similar Documents

Publication Publication Date Title
MX2010000856A (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
CR11137A (es) Valvulas prosteticas de corazon
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
BR112012023780A2 (pt) compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
ZA201003380B (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
WO2009049648A3 (en) Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
EA200900463A1 (ru) Арипипразола гемифумарат и способ его получения
WO2010061220A3 (en) Novel processes and pure polymorphs
GR20070100405A (el) Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων
WO2007110765A3 (en) Processes for the preparation of octreotide
MY150480A (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
GR1008821B (el) Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
HRP20090102T3 (en) Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof
WO2011086577A3 (en) Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
WO2010061219A3 (en) Polymorphs
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
CO6260055A2 (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma
GR1007741B (el) Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου
GR1007629B (el) Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης
GR1007907B (el) Φαρμακευτικο σκευασμα περιεχον ενα φαινοκαρβαμικο αναστολεα της ακετυλχοληνεστερασης
GR1008082B (el) Φαρμακευτικο σκευασμα περιεχον εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Legal Events

Date Code Title Description
FG Grant or registration